Joe Brice Weinberg, MD

Professor of Medicine
Associate Professor of Obstetrics and Gynecology
Professor of Immunology
Affiliate, Duke Global Health Institute
Member of the Duke Cancer Institute
Campus mail Duke Box 3396, Durham, NC 27708
Phone (919) 286-6833
Email address weinb001@duke.edu

Dr. Weinberg is a board-certified hematologist and medical oncologist who serves as Professor of Medicine and Immunology and Associate Professor of Obstetrics and Gynecology at the Duke University Medical Center, and staff physician in hematology-oncology at the Durham V.A. Medical Center. His clinical interests are in hematology and oncology, and his research focuses on blood cells, nitric oxide (NO), and leukemia. The work includes studies of resistance to infection, pathways of inflammation, and regulation of normal and leukemic cell life and death. His current work includes studies of leukemia (primarily chronic lymphocytic leukemia); the roles of NO and arginine in the resistance to malaria; and the interactions of NO, prostaglandins, and mechanical force in inflammation and arthritis.

Education and Training

  • Fellowship, Hematology Oncology, University of Utah School of Medicine, 1973 - 1976
  • Internship & Residency, University of Arkansas at Little Rock, 1969 - 1971
  • M.D., University of Arkansas at Little Rock, 1969
  • B.S., University of Arkansas, Fayetteville, 1966

Publications

Coombs, CC, Rassenti, LZ, Slager, SL, Strom, S, Weinberg, JB, Kipps, TJ, and Lanasa, MC. "Race As a Determinant of Disease Biology and Outcomes in Chronic Lymphocytic Leukemia." 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis. San Diego, CA. December 10, 2011 - December 13, 2011.: AMER SOC HEMATOLOGY, November 18, 2011.

Scholars@Duke

Christensen, DJ, Chen, Y, Oddo, J, Matta, KM, Neil, J, Davis, ED, Volkheimer, AD, Lanasa, MC, Friedman, DR, Goodman, BK, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Vitek, MP, and Weinberg, JB. "SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target." Blood 118, no. 15 (October 13, 2011): 4150-4158.

PMID
21844565
Full Text

Lanasa, MC, Allgood, SD, Slager, SL, Dave, SS, Love, C, Marti, GE, Kay, NE, Hanson, CA, Rabe, KG, Achenbach, SJ, Goldin, LR, Camp, NJ, Goodman, BK, Vachon, CM, Spector, LG, Rassenti, LZ, Leis, JF, Gockerman, JP, Strom, SS, Call, TG, Glenn, M, Cerhan, JR, Levesque, MC, Weinberg, JB, and Caporaso, NE. "Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL." Leukemia 25, no. 9 (September 2011): 1459-1466.

PMID
21617698
Full Text

Lanasa, MC, and Weinberg, JB. "Immunoglobulin class switch recombination in chronic lymphocytic leukemia." Leuk Lymphoma 52, no. 7 (July 2011): 1398-1400. (Review)

PMID
21699386
Full Text

Lanasa, MC, and Weinberg, JB. "Immunologic aspects of monoclonal B-cell lymphocytosis." Immunol Res 49, no. 1-3 (April 2011): 269-280. (Review)

PMID
21161696
Full Text

Slager, SL, Rabe, KG, Achenbach, SJ, Vachon, CM, Goldin, LR, Strom, SS, Lanasa, MC, Spector, LG, Rassenti, LZ, Leis, JF, Camp, NJ, Glenn, M, Kay, NE, Cunningham, JM, Hanson, CA, Marti, GE, Weinberg, JB, Morrison, VA, Link, BK, Call, TG, Caporaso, NE, and Cerhan, JR. "Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL." Blood 117, no. 6 (February 2011): 1911-1916.

PMID
21131588
Full Text

Riera, KM, Rothfusz, NE, Wilusz, RE, Weinberg, JB, Guilak, F, and McNulty, AL. "Interleukin-1, tumor necrosis factor-alpha, and transforming growth factor-beta 1 and integrative meniscal repair: influences on meniscal cell proliferation and migration." Arthritis Res Ther 13, no. 6 (2011): R187-null.

PMID
22087734
Full Text

Weinberg, JB, Chen, Y, Jiang, N, Beasley, BE, Salerno, JC, and Ghosh, DK. "Erratum: Inhibition of nitric oxide synthase by cobalamins and cobinamides (Free Radical Biology & Medicine (2009) 46 (1626-1632))." Free Radical Biology and Medicine 51, no. 7 (2011): 1471--.

Full Text

Jima, DD, Zhang, J, Jacobs, C, Richards, KL, Dunphy, CH, Choi, WWL, Au, WY, Srivastava, G, Czader, MB, Rizzieri, DA, Lagoo, AS, Lugar, PL, Mann, KP, Flowers, CR, Bernal-Mizrachi, L, Naresh, KN, Evens, AM, Gordon, LI, Luftig, M, Friedman, DR, Weinberg, JB, Thompson, MA, Gill, JI, Liu, Q, How, T, Grubor, V, Gao, Y, Patel, A, Wu, H, Zhu, J, Blobe, GC, Lipsky, PE, Chadburn, A, Dave, SS, and Hematologic Malignancies Research Consortium, . "Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs." Blood 116, no. 23 (December 2, 2010): e118-e127.

PMID
20733160
Full Text

Christensen, DJ, Oddo, J, Bond, K, Volkheimer, A, Chen, Y, Davis, E, Gockerman, JP, Diehl, LF, III, DCC, Moore, JO, Vitek, MP, and Weinberg, JB. "Targeting Destruction of Mcl-1 by Activation of Protein Phosphatase 2A In CLL and B-Cell Lymphomas." November 19, 2010.

Scholars@Duke

Pages